Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

We recently published a list of Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus. In this article, we are going to take ...

It is very early days for Illumina’s spatial technology, with a lot of unknowns. But two early users gave GEN a glimpse into the data quality. Neither researcher has handled the kit in-house ...

Consumables, such as sequencing kits for specific genomes, are the main revenue driver with over 70% revenue contribution. We expect strong consumables growth as customers transition to Illumina ...

Illumina (NASDAQ:ILMN – Free Report ... whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes ...

MGI shares have surged more than 50% since Beijing’s move against Illumina. Stocks of BGI and genetic sequencer maker Novogene Co. also jumped, alongside medical device and diagnostic kit makers ...

Illumina, Inc. (Nasdaq ... X single-flow-cell system alongside a cutting-edge software upgrade and new kits.

MGI shares have surged more than 50 per cent since Beijing’s move against Illumina. Stocks of BGI and genetic sequencer maker Novogene also jumped, alongside medical device and diagnostic kit makers ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...